Orange Book product · Brand (NDA)
XIMINO
MINOCYCLINE HYDROCHLORIDE
At a glance
Jul 11, 2012
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 11, 2012
14 yr 2 mo ago
Today
Patent 7919483 expires
Listed method-of-use patent (U-124) expiration.
Mar 07, 2027
in 9 mo
Patent 7541347 expires
Listed method-of-use patent (U-917) expiration.
Apr 02, 2027
in 10 mo
Patent 7544373 expires
Listed drug product patent expiration.
Apr 02, 2027
in 10 mo
Pharmaceutical detail
Active ingredient
MINOCYCLINE HYDROCHLORIDE
Strength
EQ 135MG BASE
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 201922
Product number
005
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2024EMROSIBrand (NDA)
NDA 219015 · JOURNEY
- 2020ZILXIBrand (NDA)
NDA 213690 · JOURNEY
- 2019AMZEEQBrand (NDA)
NDA 212379 · JOURNEY
- 2017MINOLIRABrand (NDA)
NDA 209269 · EPI HLTH
- 2006SOLODYNBrand (NDA)
NDA 050808 · BAUSCH
- 2001ARESTINBrand (NDA)
NDA 050781 · ORAPHARMA
- 1990MINOCINBrand (NDA)
NDA 050649 · BAUSCH
- 1982MINOCYCLINE HYDROCHLORIDEBrand (NDA)
NDA 050451 · TRIAX PHARMS
- —MINOCINBrand (NDA)
NDA 050315 · TRIAX PHARMS
- —MINOCINBrand (NDA)
NDA 050444 · REMPEX
- —MINOCINBrand (NDA)
NDA 050445 · BAUSCH
- 2022MINOCYCLINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215466 · REGCON HOLDINGS
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7919483 | Mar 07, 2027 | in 9 mo | U-124 |
| 7541347 | Apr 02, 2027 | in 10 mo | U-917 |
| 7544373 | Apr 02, 2027 | in 10 mo | Product |
